38 related articles for article (PubMed ID: 31672668)
1. Extent of surgery affects survival for papillary thyroid cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS; Sturgeon C
Ann Surg; 2007 Sep; 246(3):375-81; discussion 381-4. PubMed ID: 17717441
[TBL] [Abstract][Full Text] [Related]
2. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.
Adam MA; Pura J; Goffredo P; Dinan MA; Hyslop T; Reed SD; Scheri RP; Roman SA; Sosa JA
J Clin Endocrinol Metab; 2015 Jan; 100(1):115-21. PubMed ID: 25337927
[TBL] [Abstract][Full Text] [Related]
3. Contemporary trends in extent of surgery for differentiated thyroid cancer with extrathyroidal extension.
Montgomery KB; Fazendin JM; Chen H; Broman KK
Am J Surg; 2024 Feb; 228():173-179. PubMed ID: 37722937
[TBL] [Abstract][Full Text] [Related]
4. Extent of surgery for unilateral papillary thyroid cancer with nonsuspicious contralateral nodules by ultrasound.
Xu S; Huang H; Xian K; Wang X; Xu Z; Liu S; Liu J
Endocrine; 2024 May; ():. PubMed ID: 38703328
[TBL] [Abstract][Full Text] [Related]
5. Lobectomy in patients with differentiated thyroid cancer: experience of a Chilean tertiary center.
Fuentes I; Santana R; Espinoza M; Arteaga E; Uslar T; Baudrand R; González G; Guarda FJ; Lustig N; Mosso L; Nilo F; Valenzuela F; Domínguez F; González HE; Montero PH; Cruz F; Solar A; Domínguez JM
Endocrine; 2024 Jun; ():. PubMed ID: 38874828
[TBL] [Abstract][Full Text] [Related]
6. Psychological impacts of lobectomy and total thyroidectomy in PTC measuring 1 to 4 cm with low to intermediate risk of recurrence.
Ye Z; Wang L; Li G; Zhang P; Wei T; Zhu J; Li Z; Lei J; Gou J; Tang H
Endocrine; 2024 Jun; ():. PubMed ID: 38822895
[TBL] [Abstract][Full Text] [Related]
7. A Rare Case of Multifocal Papillary Thyroid Cancer in Bilateral Thyroid Cysts.
Chowdhury AR; Ch'ng JK; Tan CC
Case Rep Med; 2018; 2018():1656831. PubMed ID: 29849656
[TBL] [Abstract][Full Text] [Related]
8. Completion thyroidectomy for intermediate risk factors after thyroid lobectomy.
Shaha AR
Oral Oncol; 2024 Jun; 153():106240. PubMed ID: 36418200
[No Abstract] [Full Text] [Related]
9. Demographic, clinical, and surgical features of patients undergoing thyroidectomy due to thyroid lesions in Southern Iran: A cross-sectional study.
Mardani P; Koulaian S; Fouladi D; Rajaie Ramsheh FS; Amirian A; Shahriarirad S; Malekhosseini SA; Shahriarirad R
Health Sci Rep; 2024 Apr; 7(4):e2012. PubMed ID: 38567186
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the Relationship between Tumor Size and Risk in Well-Differentiated Thyroid Cancer.
Ginzberg SP; Sharpe J; Passman JE; Amjad W; Wirtalla CJ; Soegaard Ballester JM; Finn CB; Mandel S; Kelz RR; Wachtel H
Thyroid; 2024 Jun; ():. PubMed ID: 38877803
[TBL] [Abstract][Full Text] [Related]
11. Commentary on "The preferred surgical choice for intermediate-risk papillary thyroid cancer: total thyroidectomy or lobectomy? a systematic review and meta-analysis".
Mitiku AB; Bakiika E; Khatib MN; Rustagi S; Satapathy P; Zahiruddin QS; Anand A
Int J Surg; 2024 May; ():. PubMed ID: 38814321
[No Abstract] [Full Text] [Related]
12. A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.
Ruiz EML; Niu T; Zerfaoui M; Kunnimalaiyaan M; Friedlander PL; Abdel-Mageed AB; Kandil E
Surgery; 2020 Jan; 167(1):73-79. PubMed ID: 31711617
[TBL] [Abstract][Full Text] [Related]
13. Total thyroidectomy versus lobectomy for papillary thyroid cancer: A systematic review and meta-analysis.
Zhang C; Li Y; Li J; Chen X
Medicine (Baltimore); 2020 Feb; 99(6):e19073. PubMed ID: 32028431
[TBL] [Abstract][Full Text] [Related]
14. Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer.
Xu S; Huang H; Dong H; Wang X; Xu Z; Liu S; Liu J
BMC Cancer; 2023 Sep; 23(1):880. PubMed ID: 37723469
[TBL] [Abstract][Full Text] [Related]
15. Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada.
Rajab M; Payne RJ; Forest VI; Pusztaszeri M
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077677
[TBL] [Abstract][Full Text] [Related]
16. Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution.
Kim H; Kim K; Bae JS; Kim JS
Sci Rep; 2022 Aug; 12(1):13548. PubMed ID: 35941209
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Survival in Patients With Papillary Thyroid Cancer Who Did Not Undergo Prophylactic Central Lymph Node Dissection: A SEER-Based Study.
Song JL; Li LR; Xu ZL; Li JJ; Sun SR; Chen C
World J Oncol; 2022 Jun; 13(3):136-144. PubMed ID: 35837319
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Differentiated Thyroid Cancer - Risk Adapted Therapy, Genetic Profiling and Clinical Staging.
Reiners C; Drozd VM
Front Endocrinol (Lausanne); 2021; 12():755323. PubMed ID: 34690935
[No Abstract] [Full Text] [Related]
19. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
